Company intelligence / Profile preview

LB Abnoba Herbaria

Pforzheim, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

Abnoba GmbH is a specialized pharmaceutical company focused on the development and manufacture of mistletoe-based therapies for integrative oncology. The company's flagship product line, abnobaVISCUM, consists of various mistletoe extracts (Viscum album) tailored to specific host trees and concentrations. These therapies are used as supportive treatments in cancer care to improve quality of life, reduce side effects of conventional treatments, and potentially stimulate the immune system. Abnoba operates with a focus on anthroposophic medicine while maintaining modern GMP manufacturing standards for its biological products.

Therapeutic areas: Oncology
Modalities: BiologicPlant-derived extractProtein
Industry: Biotech

Beyond the preview

Go deeper on LB Abnoba Herbaria.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LB Abnoba Herbaria.

Explore the full profile